Skip to content. | Skip to navigation

Personal tools

Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1


Secondary managing bodies

logo ENSL logo ucb1

You are here: Home

Search results

71 items matching your search terms.
Filter the results.
Item type

























New items since



Sort by relevance · date (newest first) · alphabetically
Association of IFNAR1 and IFNAR2 with COVID-19 severity
The Lancet Microbe: Yaugel-Novoa M., Bourlet T., Longet S., Botehlo-Nevers E, Paul S. https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00095-2/fulltext
Located in Teams / Paul S - GIMAP / Actualités
mTOR Activation Underlies Enhanced B Cell Proliferation and Autoimmunity in PrkcdG510S/G510S Mice
Moreews M ; Mathieu AL, Pouxvielh K... Marçais A, Walzer T, Belot A
Located in Teams / Walzer T - LYACTS / Actualités
New publication COVID Nature communication
New publication - VIV Team in Nature communication
Located in Teams / Dreux M - VIV / News
Prior SARS-CoV-2 infection enhances and reshapes spike protein-specific memory induced by vaccination
Located in Teams / Walzer T - LYACTS / Actualités
An inventory of adjuvants used for vaccination in horses: the past, the present and the future.
Carnet F, Perrin-Cocon L, Paillot R, Lotteau V, Pronost S, Vidalain PO.
Located in Teams / VIDALAIN PO - VIRIMI / News
Interferon-dependent and independent mechanisms drive Hepatitis Delta Virus interference on Hepatitis B Virus RNA production
Lucifora et al., Journal of Hepatology, 2023 / Team HepVir
Located in Teams / Durantel D - HepVir / What's new for us?
Farnesoid X receptor alpha ligands inhibit hepatitis delta virus in vitro replication and virion infectivity
Legrand, Lucifora et al., Hepatology Communications, 2023 / Team VIRIMI and Team HepVir
Located in Teams / Durantel D - HepVir / What's new for us?
Last publication form the team
Grass, V. et al., Communication Biology 2022, VIV Team.
Located in Teams / Dreux M - VIV / News
Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against HBV
Lamrayat et al., Antiviral Research, 2023 / Team HepVir
Located in Teams / Durantel D - HepVir / What's new for us?
A stable hepatitis D virus-producing cell line for host target and drug discovery
Bach, Lucifora et al., Antiviral Research, 2023 / Team HepVir
Located in Teams / Durantel D - HepVir / What's new for us?